Key result
Epstein-Barr virus infection can cause severe cardiovascular complications, including coronary artery lesions, myocarditis, and heart failure, with an estimated mortality rate of 15% to 50% among reported cases.
Why the study?
Cardiovascular involvement in Epstein-Barr virus infection can lead to severe outcomes, but reliable large-scale data and evidence-based guidance for its management are lacking.
This review synthesizes current knowledge on the pathogenesis, classification, treatment, and prognosis of cardiovascular complications associated with Epstein-Barr virus infection to enhance clinical recognition and management.
Answers are grounded in this paper and cite their sources.
EBV cardiac complications warrant prompt evaluation to curb mortality; leaves open evidence-based management guidance.
Cardiovascular involvement is an uncommon but severe complication of Epstein-Barr virus (EBV) infection caused by direct damage and immune injury. Recently, it has drawn increasing attention due to its dismal prognosis. It can manifest in various ways, including coronary artery dilation (CAD), coronary artery aneurysm (CAA), myocarditis, arrhythmias, and heart failure, among others. If not treated promptly, cardiovascular damage can progress over time and even lead to death, which poses a challenge to clinicians. Early diagnosis and treatment can improve the prognosis and reduce mortality. However, there is a lack of reliable large-scale data and evidence-based guidance for the management of cardiovascular damage. Consequently, in this review, we attempt to synthesize the present knowledge of cardiovascular damage associated with EBV and to provide an overview of the pathogenesis, classification, treatment, and prognosis, which may enhance the recognition of cardiovascular complications related to EBV and may be valuable to their clinical management.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2023) conducted a review in Cardiovascular involvement in Epstein-Barr virus infection (n=54). Epstein-Barr virus infection was evaluated on Cardiovascular manifestations and prognosis. Epstein-Barr virus infection can cause severe cardiovascular complications, including coronary artery lesions, myocarditis, and heart failure, with an estimated mortality rate of 15% to 50% among reported cases.
Synapse has enriched 10 related papers. Consider them for comparative context: